|
|
||||||||
Thoracic Imaging |
1 From the Institute of Clinical Radiology (S.D., H.L., R.W., Z.P., S.H., T.K., M.E., N.R., P.E.P.) and the Gerhard Do- magk Institute of Pathology (T.M.Y.), University of Münster, Albert-Schweitzer-Str 33, D-48129 Münster, Germany. Received September 30, 1998; revision requested November 17; revision received January 14, 1999; accepted April 15. Address reprint requests to S.D. (e-mail: diestef@uni-muenster.de).
| Abstract |
|---|
|
|
|---|
MATERIALS AND METHODS: Two radiologists recorded pulmonary nodules at standard-dose (250 or 100 mA, pitch of 1; 200 mA, pitch of 2) or low-dose CT (50 or 25 mA, pitch of 1 or 2) in five postmortem specimens and 75 patients. Nodules were assessed by size (5 mm or smaller, 610 mm, or larger than 10 mm) and by diagnostic confidence ("definite nodule," "definite lesion, not classic nodule," or "questionable lesion, possibly representing a vessel") with the Wilcoxon signed rank test. Artifacts depicted at low-dose CT were recorded.
RESULTS: There were no statistically significant differences in the number of nodules detected at standard- or low-dose CT except in nodules 5 mm or smaller that were assessed as definite nodules at standard- or low-dose CT (25 mA, pitch of 2) (472 vs 397, P < .05). Artifacts that possibly interfered with nodule detection were observed exclusively at CT with 25 mA and a pitch of 2.
CONCLUSION: Pulmonary nodules were detected reliably at CT with 50 mA and pitch of 2 or with 25 mA and a pitch of 1. However, further reduction of the dose to that used at chest radiography was associated with a significant decrease in the number of nodules 5 mm or smaller that were detected, possibly due to artifacts.
Index terms: Computed tomography (CT), comparative studies, 60.12115 Computed tomography (CT), experimental studies, 60.12115 Computed tomography (CT), radiation exposure, 60.12115, 60.47 Lung, nodule, 60.281 Lung neoplasms, CT, 60.12115, 60.281 Lung neoplasms, diagnosis, 60.281
| Introduction |
|---|
|
|
|---|
Compared with other radiologic modalities, CT is associated with a relatively high level of radiation. Therefore, CT is regarded as the main source of medical radiation exposure in industrialized countries (610). In the literature, the effective dose equivalent from a single CT examination of the chest is reported to range from 2 to 25 mSv, depending on the CT scanner and the examination protocol used (6,7,914). These doses markedly exceed effective dose equivalents received at chest radiography (
0.3 mSv) by factors of 10100 (11,13,14). In particular, radiation exposure causes concern in patients, especially children, with benign disease (15,16).
Findings in recent publications suggest that substantial dose reduction is possible at chest CT because of its high inherent contrast and because of the low radiation absorption of the lung (1621).
The aim of this study was to assess the accuracy of low-dose spiral CT for the detection of pulmonary nodules compared with that of CT protocols with established examination parameters. We were particularly interested in the diagnostic value of low-dose CT with a radiation exposure equivalent to that used at chest radiography.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Patients
The study population consisted of 75 consecutive patients (36 women, 39 men; age range, 1978 years; mean age, 56 years) with proved hematogenous metastases from malignant tumors (carcinoma, n = 64; sarcoma, n = 10; melanoma, n = 1) and with known pulmonary nodules. Patients were referred for clinically indicated chest CT during a study period of 15 months (July 1995 to September 1996). Written informed consent was obtained to perform an additional low-dose CT examination of the chest. Patients not well enough to tolerate the additional examination time were excluded from the study. The study design was approved by the local ethics committee and the governmental radiation protection board.
Protocols
All postmortem and patient examinations were performed with the same helical CT scanner (Tomoscan SR 7000; Philips, Eindhoven, the Netherlands). Lung specimens and patients were examined at CT with established protocols (standard-dose CT) and with reduced radiation exposure (low-dose CT) in one session (Figs 1, 2).
|
|
|
|
|
|
For another part of the study, the tube current at standard-dose CT was reduced to 100 mA after an analysis of the findings from the previous studies and from the literature (9,11,12). At this time, the manufacturer provided an experimental 25-mA setting. As with the higher settings for tube current, we initially compared findings at standard-dose CT with findings at low-dose CT with a pitch of 1 (10-mm collimation; table feed, 10 mm per rotation; 10-mm reconstruction interval). For further dose reduction, the pitch was increased again by reducing collimation (5-mm collimation; table feed, 10 mm per rotation; 5-mm reconstruction interval). To keep all of the other parameters between standard- and low-dose CT constant, we also increased the pitch at standard-dose CT, while maintaining a constant signal-to-noise ratio, by increasing the tube current to 200 mA (24). A total of 36 patients were examined by using a tube current of 25 mA.
Thus, three different steps of dose reduction were achieved at low-dose CT, which represented approximately 20%, 10%, and 5% of the dose associated with the original standard-dose CT protocol. Table 1 summarizes the corresponding examination protocols.
|
Analysis was performed independently and in random order by two board-certified radiologists (S.D., R.W.) who had similar experience with spiral CT in pulmonary nodules. The readers were not aware of the specimen number, the patient's identity, or the precise examination protocol. They could, however, identify standard- and low-dose settings because of differences in image noise. There were 4-week intervals between analysis of corresponding studies from one specimen or patient to prevent recognition of the findings, and corresponding low- and standard-dose CT images were analyzed in alternating fashion to exclude bias from learning effects.
Each pulmonary nodule was recorded in a standardized form: The lesion size was measured in millimeters; particular attention was paid to the correct classification of the nodule into three size categories (
5 mm, 610 mm, >10 mm) by using the caliper on the CT scanner, which was transferred to a strip of cardboard that could be held against the nodule. No electronic measurement was obtained on the monitor. The location of the lesion was noted by recording the section position at which the lesion was best displayed and by marking the location of the lesion at the respective levels within the section in a schematic drawing of the lung.
The degree of diagnostic confidence was also recorded in three categories: An area of attenuation observed by the readers was recorded as a "definite nodule" if it was round or slightly oblong (long axis/short axis < 2) and well defined. It was recorded as a "definite lesion, not classic nodule" if it was more oblong (long axis/short axis > 2) or ill defined but was believed to represent a true lesion. If the reader was uncertain whether an area of attenuation represented a true lesion or a pulmonary vessel that was imaged in cross-section, it was recorded as a "questionable lesion, possibly representing a vessel."
Analysis was performed separately for nodules detected by individual readers and for the total of nodules detected by both readers. No consensus opinion was obtained for the detection of nodules.
Artifacts
During the individual reading session, both readers recorded if the CT image was degraded by artifacts that were believed to potentially interfere with the detection of pulmonary nodules. All examinations in which artifacts were recorded were assessed more precisely during a second reading session by both readers in consensus: The presence of artifacts was recorded for every CT image. To correspond to the classification of nodule size, artifacts were classified by the size of the nodules that they possibly obscured, as follows: 5 mm or smaller, 610 mm, or larger than 10 mm. The subject's height and body weight were recorded for correlation with the presence and classification of artifacts.
Histopathologic Analysis
After the CT examination, each lung specimen was cut into slices with a thickness of approximately 10 mm in an orientation identical to that on the CT images (Fig 1c). For correlation of CT and histopathologic findings, a total of 27 nodules (range, three to nine per specimen; mean, 5.4) 10-mm or smaller (range, 28 mm; mean, 4.9 mm) that were all recorded as a definite nodule or as a definite lesion, not classic nodule by at least one observer at one dose setting were selected. These nodules were embedded in paraffin, cut on a microtome, and stained with hematoxylin-eosin.
Statistical Analysis
Pulmonary nodules demonstrated in the same lung with different examination protocols represented paired data, which were not normally distributed. Therefore, the Wilcoxon signed rank test was used to assess differences in the detection of nodules at the corresponding CT examinations. P values less than or equal to .05 indicated a statistically significant difference (25).
From the true-positive, false-positive, and false-negative findings, the sensitivity and positive predictive value of low-dose CT were calculated by using findings from the corresponding standard-dose CT as the standard. As small pulmonary nodules are not demonstrated reliably in fixed lung specimens, histopathologic findings were not used as the standard. True-negative findings could not be recorded for individual nodules in lungs with multiple lesions in lung specimens or in patients. Therefore, specificity and negative predictive value could not be calculated (26).
Calculation of Effective Dose Equivalents
Effective dose equivalents for the different standard- and low-dose CT protocols were calculated according to the investigations by Lenzen et al (11), members from our group, who used the same CT scanner that was used in this study. In that study, effective dose equivalents were determined by using a male RANDO phantom (Phantom Laboratory, Salem, NY), thermoluminescence dosimetry, and calculations with conversion factors (27,28). With this CT scanner, a collimation of 5 mm, pitch of 2, and a tube current of 50 mA, effective dose equivalents of 0.6 mSv (men) and 1.1 mSv (women) were found. The differences were due to the fact that the breast contributes substantially to the effective dose equivalent in women (11).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
There was also no significant difference in the proportion of the three categories of diagnostic confidence. For both readers, the proportion of definite nodules increased with lesion size and the number of questionable lesions that possibly represented vessels decreased with lesion size (Table 8). The sensitivity and positive predictive value of low-dose CT, with standard-dose CT as the standard, are presented in Table 9.
|
|
|
|
By using low-dose CT protocols 1, 2, and 3 (with doses that were 20% or 10% of the initial standard dose), a total of 865 nodules were detected by the two readers, whereas 793 nodules were detected by the readers on images obtained at the corresponding standard-dose CT protocols (Tables 35). The number of nodules detected at all three of the low-dose CT protocols was larger than the number detected at the corresponding standard-dose CT protocols, almost exclusively because of the findings of observer 1. Observer 2, on the contrary, diagnosed more nodules at standard-dose CT than at low-dose CT with protocols 13. The difference in the number of nodules detected at standard-dose CT and at low-dose CT was 10% or less and was not statistically significant (P > .05) (Table 7). Also, there was no significant difference in the diagnostic confidence between findings at low-dose CT and at standard-dose CT. As with the postmortem studies, the percentage of definite nodules increased with lesion size (Table 8).
The sensitivity of low-dose CT for nodules 5 mm or smaller, with standard-dose CT as the standard, ranged from 36% to 67% for both readers, with marked variation for individual readers (18%88%). For 610-mm nodules, sensitivity ranged from 72% to 89% for both readers, with less variation between individual readers (60%90%). For lesions larger than 10 mm, sensitivity of low-dose CT ranged from 91% to 100%, with little variation between individual readers (86%100%). Findings were similar for positive predictive values (Table 9).
However, with the lowest-dose CT protocol (low-dose CT protocol 4, 5% of the dose of the standard protocol), a smaller total number of nodules were diagnosed (983 vs 1,077 at standard-dose CT, P > .05), and there were significantly fewer lesions diagnosed as definite nodules (779 vs 885, P < .05) (Table 6). This was exclusively due to the smaller number of definite nodules that were 5 mm or smaller (397 vs 472, P < .05) (Table 7). When standard-dose CT with 200 mA was used as the standard, the sensitivity of low-dose CT with 25 mA and a pitch of 2 was 78% for all nodules, 67% for nodules 5 mm or smaller, 89% for 610-mm nodules, and 100% for nodules larger than 10 mm. Positive predictive values were 86%, 78%, 93%, and 97%, respectively.
Artifacts
No artifacts that interfered with the detection of pulmonary nodules were recorded at low-dose CT in the postmortem studies or patient studies with dose reductions between 20% and 10% (low-dose CT protocols 13). The images were, however, more grainy than those obtained at standard-dose CT. Artifacts were recorded only at low-dose CT when the dose was reduced to 5% (low-dose CT protocol 4). With this protocol, no artifacts were recorded in three of the 22 patients examined (body height
179 cm; body weight
80 kg) (Fig 4a).
|
|
In 16 patients, artifacts that possibly interfered with the detection of 610-mm nodules were recorded; these artifacts involved the uppermost one to 11 (mean, four) images in the lung apex. In only two of the 16 patients did these artifacts involve more than six images; these patients' body weights were 95 kg (11 images) and 107 kg (eight images) (Fig 4b). In three patients, artifacts were present below the level of the aortic arch; these were recorded as artifacts that only potentially obscured nodules that were 5 mm or smaller. In no patient were artifacts seen below the inferior margin of the scapula.
We looked for statistically significant differences in the detection of nodules on standard- and low-dose CT images that were degraded by artifacts by comparing the number of lesions detected above the level of the aortic arch. No significant difference was found between standard- and low-dose CT in the total number of nodules observed (162 vs 159), nodules 5 mm or smaller (110 vs 103), and definite nodules 5 mm or smaller (72 vs 60).
Effective Dose Equivalents at Standard- and Low-Dose CT
By applying the data reported by Lenzen et al (11) to the different CT protocols used in this study, the effective dose equivalents were found to range from 8.0 (men) and 13.5 (women) (250 mA; 120 kV; 10-mm collimation; table feed, 10-mm per rotation, 10-mm reconstruction interval) to 0.3 (men) and 0.55 (women) (25 mA, 120 kV; 5-mm collimation; table feed, 10-mm per rotation, 5-mm reconstruction interval) (Table 10).
|
| DISCUSSION |
|---|
|
|
|---|
In our study, dose reduction to 10%25% of the corresponding dose at standard-dose CT was shown to cause no significant difference in the detection of pulmonary nodules, when compared with detection at standard-dose settings. In fact, when we compared findings at low-dose CT with 5-mm collimation with findings at standard-dose CT with 10-mm collimation (Table 3), we found that more lesions were detected at low-dose CT, possibly because of decreased partial volume effects (30). Also, the readers' diagnostic confidence did not change significantly with these examination protocols. The effective dose equivalent of these settings was in the range of 0.62.7 mSv, which corresponded to the effective dose equivalent for the acquisition of two to 10 chest radiographs (two views). Our findings and those of other investigators (29) suggest that these settings are sufficient for the detection of pulmonary nodules in most circumstances.
Although there was no superior standard for assessing the sensitivity and positive predictive value with standard-dose CT and although histopathologic examination of the lung specimens did not allow us to assess the false-negative CT findings, histologic findings in nodules detected at CT suggested that there are few false-positive results at both low- and standard-dose CT. The large number of focal lesions due to bronchopneumonia may explain the high proportion of lesions that were classified as definite lesions not classic nodules in the postmortem studies. The marked variation between the two readers and the two dose protocols is most likely due to the large number of lesions in individual lungs.
Further dose reduction was achieved in our study with a tube current of 25 mA and a pitch of 2, which in our CT scanner resulted in an effective dose equivalent of 0.3 mSv in the men and 0.55 mSv in the women; this was comparable to the dose associated with the acquisition of one to two chest radiographs in two views. When we compared this low-dose CT protocol with the standard-dose protocol, no significant differences were found in the detection of nodules larger than 5 mm. There were, however, significantly fewer nodules detected that measured 5 mm or less. Also, artifacts were observed with this protocol; they degraded some images in the lung apex, particularly in obese patients. The use of this protocol can, therefore, be recommended only if it is acceptable that nodules 5 mm or smaller may be missed, particularly those in the extreme lung apex.
In our study, the sensitivity and positive predictive value of low-dose CT for nodules 10 mm or smaller was better with a 5-mm collimation and pitch of 2 (effective section thickness, 6.5 mm) than with a 10-mm collimation and pitch of 1 (effective section thickness, 10 mm). This was most likely due to a reduction of partial volume effects and slightly overlapping image reconstruction; this was particularly true for the low-dose CT protocol 2, which was compared with a standard-dose CT protocol with 10-mm collimation and no overlapping reconstruction. Certainly, the increased number of images resulting from a decreased collimation and reconstruction interval did not lead to a decrease in the sensitivity or positive predictive value.
A limitation of our study is the fact that the results cannot be automatically transferred to scanners from different manufacturers or to different scanners of the same model, as identical settings for tube current, tube voltage, collimation, and table feed do not necessarily result in identical image quality or effective dose equivalents. For example, with modern scanners that have solid-state detectors instead of gas detectors, further dose reduction can be expected, with no change in the signal-to-noise ratio (31). Therefore, image quality and effective dose equivalents should be determined individually for specific scanners. Ideally, the image quality, as determined by the signal-to-noise ratio, that is required to solve a specific clinical problem should be defined, and the examination protocol should be selected accordingly (32).
Obviously, in our study, low-dose CT of the chest was not studied in children. However, as radiation absorption decreases with the third order of object diameter, the exposure can be reduced to approximately 50% with every 4-cm decrease of the patient's mediolateral diameter, while maintaining an identical signal-to-noise ratio (31). For this reason, we apply low-dose settings of 25 mA with a pitch of 2 in all infants and children who undergo chest CT for pulmonary nodules.
In our study, there was no significant difference in the number of pulmonary nodules detected at chest CT with standard examination parameters and the number detected at low-dose CT with 10%25% of radiation exposure of the corresponding standard protocol. Only further reduction of doses to the exposure levels used at chest radiography was associated with significantly decreased sensitivity for nodules 5 mm or smaller; there were no significant differences for nodules larger than 5 mm.
The low-dose CT settings used in our study certainly provided images of sufficient quality to exclude or confirm pulmonary nodules in the presence of an equivocal chest radiograph or at screening for benign (eg, pulmonary arteriovenous malformations [33]) or malignant (eg, bronchogenic carcinoma in smokers [34,35]) disease.
| Footnotes |
|---|
Deceased Author contributions: Guarantor of integrity of entire study, S.D.; study concepts, S.D., P.E.P.; study design, S.D., H.L.; definition of intellectual content, S.D., H.L., N.R.; literature research, S.D., S.H., T.K.; clinical studies, S.D., R.W., S.H.; experimental studies, S.D., H.L., M.E., Z.P., T.M.Y.; data acquisition and analysis, S.D., T.K., S.H.; statistical analysis, S.D., T.K., S.H.; manuscript preparation and editing, S.D.; manuscript review, S.D., H.L., N.R.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |